Showing results (1-10 of 637) with videos related to
Sort By:
Pageof 64
Neurology|April 1, 1993
Levodopa, melanoma, and Parkinson's diseaseW J Weiner, C Singer, J R Sanchez-Ramos, et al.European Neurology|January 1, 1992
Autonomic dysfunction in men with Parkinson's diseaseC Singer, W J Weiner, J R Sanchez-RamosNeurology|January 1, 1993
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-Ramos, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapyS A Factor, J R Sanchez-Ramos, W J WeinerJournal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-RamosJournal of Neurochemistry|June 1, 1988
Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidenceJ R Sanchez-Ramos, P Michel, W J Weiner, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's diseaseE S Molho, S A Factor, W J Weiner, et al.Journal of Neurochemistry|January 1, 1992
21-aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicityJ R Sanchez-Ramos, S Song, D C Mash, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Sleep disorders and sleep effect in Parkinson's diseaseS A Factor, T McAlarney, J R Sanchez-Ramos, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosisJ R Sanchez-Ramos, S A Factor, W J Weiner, et al.Pageof 64